Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.1860
+0.0024 (1.31%)
At close: Aug 10, 2026
Northwest Biotherapeutics Market Cap
Northwest Biotherapeutics has a market cap or net worth of $313.98 million as of August 10, 2026. Its market cap has decreased by -14.48% in one year.
Market Cap
313.98M
Enterprise Value
388.67M
Revenue
1.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.19
ChartMarket Cap Chart
Since December 14, 2001, Northwest Biotherapeutics's market cap has increased from 10.29M to 313.98M, an increase of 2,951.55%. That is a compound annual growth rate of 14.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 313.98M | -12.39% |
| Dec 31, 2025 | 358.39M | -1.53% |
| Dec 31, 2024 | 363.95M | -55.71% |
| Dec 29, 2023 | 821.84M | -1.00% |
| Dec 30, 2022 | 830.10M | 25.14% |
| Dec 31, 2021 | 663.34M | -47.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 564.45M |
| CytoDyn | 256.12M |
| Glorywin Entertainment Group | 182.41M |
| Vaxart | 138.74M |
| NDT Pharmaceuticals | 105.07M |
| HST Global | 99.00M |
| Biomind Labs | 62.06M |
| Cell Source | 55.94M |